Literature DB >> 14504111

Posttransplantation lymphoproliferative disorders.

Pietro Andreone1, Annagiulia Gramenzi, Stefania Lorenzini, Maurizio Biselli, Carmela Cursaro, Stefano Pileri, Mauro Bernardi.   

Abstract

Posttransplantation lymphoproliferative disorders include a wide spectrum of diseases ranging from hyperplastic-appearing lesions to frank non-Hodgkin lymphoma. More than 90% of these disorders are Epstein-Barr virus-associated lesions of B-cell origin that arise in the setting of pharmacologic immunosuppression after transplantation. With the increased use of organ transplantation and intensive immunosuppression, posttransplantation lymphoproliferative disorders are becoming more common. The prognosis is often poor, with most patients dying despite receiving treatment. The aim of this review is to report the most recent knowledge about the clinical features, diagnosis, prophylaxis, and treatment of posttransplantation lymphoproliferative disorders, which can be useful to physicians and health assistants dealing with these life-threatening, posttransplantation clinical entities in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504111     DOI: 10.1001/archinte.163.17.1997

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  16 in total

1.  Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder.

Authors:  E A Engels; J Preiksaitis; A Zingone; O Landgren
Journal:  Am J Transplant       Date:  2012-02-02       Impact factor: 8.086

2.  Investigation of epstein-barr virus as a potential cause of B-cell non-Hodgkin lymphoma in a prospective cohort.

Authors:  Anneclaire J De Roos; Otoniel Martínez-Maza; Keith R Jerome; Dana K Mirick; Kenneth J Kopecky; Margaret M Madeleine; Larry Magpantay; Kerstin L Edlefsen; Andrea Z Lacroix
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-24       Impact factor: 4.254

3.  Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States.

Authors:  Scott C Quinlan; Ruth M Pfeiffer; Lindsay M Morton; Eric A Engels
Journal:  Am J Hematol       Date:  2011-02       Impact factor: 10.047

4.  Post-transplant lymphoproliferative disorder localized in the colon after liver transplantation: report of a case.

Authors:  Min Jung Kim; Seong Hyeon Yun; Ho-Kyung Chun; Woo Yong Lee; Yong Beom Cho
Journal:  Surg Today       Date:  2009-12-08       Impact factor: 2.549

5.  Lymphomas differ in their dependence on Epstein-Barr virus.

Authors:  David T Vereide; Bill Sugden
Journal:  Blood       Date:  2010-11-18       Impact factor: 22.113

6.  Plasma markers of B-cell activation and clonality in pediatric liver and hematopoietic stem cell transplant recipients.

Authors:  Eric A Engels; Barbara Savoldo; Ruth M Pfeiffer; Rene Costello; Adriana Zingone; Helen E Heslop; Ola Landgren
Journal:  Transplantation       Date:  2013-02-15       Impact factor: 4.939

7.  Herpesvirus Infections and Risk of Frailty and Mortality in Older Women: Women's Health and Aging Studies.

Authors:  George C Wang; Christina Han; Barbara Detrick; Vincenzo Casolaro; David M Levine; Linda P Fried; Jeremy D Walston
Journal:  J Am Geriatr Soc       Date:  2016-04-30       Impact factor: 5.562

8.  Murine Models of Epstein-Barr Virus-Associated Lymphomagenesis.

Authors:  Elshafa Hassan Ahmed; Robert A Baiocchi
Journal:  ILAR J       Date:  2016

9.  Hypomagnesemia and risk of post-transplant lymphoproliferative disorder in liver transplant recipients.

Authors:  Parag Mahale; Gregory J Mckenna; Giovanna Saracino; Linda Jennings; Sam M Mbulaiteye; Göran B Klintmalm; Eric A Engels
Journal:  Transpl Int       Date:  2020-11-09       Impact factor: 3.782

10.  Ocular adnexal non-Hodgkin's lymphoma: a review of epidemiology and risk factors.

Authors:  Roxana Moslehi; Maria J Schymura; Seema Nayak; F Bruce Coles
Journal:  Expert Rev Ophthalmol       Date:  2011-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.